Last mentioned: Mar 15, 2026
Earnings Release
Expected date for Q4 and full-year 2025 financial results and clinical updates.
Earnings Preview
Market analysts highlight Tuesday as a key reporting date for both COYA and INKT.
MiNK Collaboration
MiNK Therapeutics announces partnership with C-Further for pediatric cancer therapies, stock rises 60%.
Coya Therapeutics and MiNK Therapeutics are scheduled to report quarterly financial results this Tuesday, with investors focused on cash runway and clinical progress. These updates come at a critical juncture for both companies as they advance novel cell therapies for neurodegeneration and oncology, respectively.
Coya Therapeutics and MiNK Therapeutics are scheduled to release quarterly financial results this Tuesday, providing critical updates on their clinical pipelines and cash runways. Investors are closely monitoring MiNK's recent pediatric cancer collaboration and Coya's progress in neurodegenerative Treg therapies.